OMI:NYE-Owens & Minor Inc (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 15.73

Change

+1.20 (+8.26)%

Market Cap

N/A

Volume

1.20M

Analyst Target

USD 15.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

+0.45 (+0.20%)

USD 44.41B
CAH Cardinal Health Inc

+0.41 (+0.38%)

USD 26.96B
MCK McKesson Corporation

-0.08 (-0.02%)

N/A
NVG Nuveen AMT Free Municipal Cred..

+0.03 (+0.23%)

N/A

ETFs Containing OMI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -18.37% 20% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.37% 20% F 9% A-
Trailing 12 Months  
Capital Gain -3.08% 20% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.08% 20% F 15% F
Trailing 5 Years  
Capital Gain 178.90% 80% B- 93% A
Dividend Return 0.40% 20% F 2% F
Total Return 179.30% 80% B- 92% A
Average Annual (5 Year Horizon)  
Capital Gain 81.77% 100% F 97% N/A
Dividend Return 81.81% 100% F 97% N/A
Total Return 0.04% 20% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 174.74% 20% F 4% F
Risk Adjusted Return 46.82% 40% F 64% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector